As of January 23, 2025, Integragen SA (ALINT.PA) has a market cap of $4.312 million USD. According to our data, Integragen SA is ranked No.9083 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $4.31 M |
10.71%
|
Dec 31, 2024 | $3.89 M |
-36.80%
|
Dec 29, 2023 | $6.16 M |
-26.12%
|
Dec 30, 2022 | $8.34 M |
9.21%
|
Dec 31, 2021 | $7.64 M |
-45.95%
|
Dec 31, 2020 | $14.13 M |
102.97%
|
Dec 31, 2019 | $6.96 M |
-9.01%
|
Dec 31, 2018 | $7.65 M |
-56.30%
|
Dec 29, 2017 | $17.51 M |
-25.07%
|
Dec 30, 2016 | $23.37 M |
-25.00%
|
Dec 30, 2015 | $31.16 M |
-15.51%
|
Dec 31, 2014 | $36.88 M |
16.30%
|
Dec 31, 2013 | $31.71 M |
-34.29%
|
Dec 28, 2012 | $48.26 M |
-12.50%
|
Dec 30, 2011 | $55.15 M |
33.33%
|
Dec 30, 2010 | $41.36 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Park Hotels & Resorts
PK
|
$2.83 B |
0.000 M
|
USA
|
Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
Pacific Biosciences
PACB
|
$0.53 B |
-0.000 M
|
USA
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
10x Genomics
TXG
|
$1.97 B |
0.229 B
|
USA
|
Market Cap | = | ALINT.PA Stock Price | * | ALINT.PA Shares Outstanding |
= | $0.62 | * | 6.62 M | |
= | $4.31 M |